Publications by authors named "Junnji Mishima"
Int Urol Nephrol
February 2013
Article Synopsis
- The study aimed to evaluate the safety and effectiveness of mirabegron for patients with overactive bladder (OAB) who do not respond to antimuscarinic medications or have benign prostatic hyperplasia (BPH).
- A total of 97 patients were treated with mirabegron and showed significant improvement in OAB symptoms, with an effectiveness rate of 85.2% in newly diagnosed patients and 61.6% in those unresponsive to antimuscarinics.
- The results indicated that mirabegron is comparable to antimuscarinic treatments, improves symptoms related to BPH, and has a low incidence of mild side effects, supporting its safe use.
